Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies
2021 · Molecular Cancer · 361 citations
https://doi.org/10.1186/s12943-020-01298-z
M
Mulong Du
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
285
Papers
5.8K
Citations
39
h-index
126
i10-index
Mulong Du is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: RNA modifications and cancer & Cancer-related molecular mechanisms research & Epigenetics and DNA Methylation. The author has an h-index of 39, co-authored 243 publications.
ORCID: 0000-0002-2733-6490Papers by this author
worksExosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3–eIF3h interaction
2022 · Molecular Cancer · 259 citations
https://doi.org/10.1186/s12943-021-01471-y
Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer
2015 · Scientific Reports · 119 citations
https://doi.org/10.1038/srep10437
KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome
2017 · Molecular Cancer · 89 citations
https://doi.org/10.1186/s12943-017-0613-z
The biogenesis and biological function of PIWI-interacting RNA in cancer
2021 · Journal of Hematology & Oncology · 78 citations
https://doi.org/10.1186/s13045-021-01104-3
Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer
2023 · Cell Reports Medicine · 69 citations
https://doi.org/10.1016/j.xcrm.2023.100974
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat